BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Novartis Corporation’s Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

  August 27, 2008

   · 

  17 min read
• FDA

  FDA Clears Stereotaxis, Inc. Magnetic Radio Frequency Guidewire for Peripheral Chronic Total Occlusions

  August 27, 2008

   · 

  4 min read
• Policy

  Masimo Corporation Announces Dismissal of Litigation Brought by Shaklee and NIR Diagnostics

  August 27, 2008

   · 

  2 min read
• Biotech Bay

  Cutera, Inc. Launches its New Pearl Fractional Device

  August 27, 2008

   · 

  3 min read
• BioCapital

  K2M Enters the International Spine Market; CE Mark Enables Medical Device Company to Sell Overseas

  August 27, 2008

   · 

  1 min read
• FDA

  Cordis Corporation’s CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Receives CE Mark Approval for Treatment of Heart Attacks

  August 27, 2008

   · 

  3 min read
• Drug Development

  Cell Genesys, Inc. Stops Cancer Trial on Higher Deaths

  August 27, 2008

   · 

  6 min read
• Drug Development

  NexMed Says It Will Not File NDA for Nail Drug

  August 27, 2008

   · 

  2 min read
• Policy

  U.S. FDA Seeks More Data for Johnson and Johnson Pharmaceutical Research and Development, LLC (CA) (JOBS) Schizophrenia Drug

  August 27, 2008

   · 

  3 min read
• Drug Development

  UK’s NICE Recommends Novartis Pharmaceuticals UK Limited Eye Drug Lucentis

  August 27, 2008

   · 

  4 min read